PCDHGB7 expression in LUAD was associated with gene mutations such as LRP1B, STK11, and KEAP1. Of note, these genes mutations have been shown to have predictive effects on immune therapy for lung cancer in previous studies (Figure 2D) (4, 22). This evidence concerns the gene PCDHGB7 and lung carcinoma.